129 related articles for article (PubMed ID: 30277105)
1. The size and depth of lesions measured by endoscopic ultrasonography are novel prognostic factors of primary gastric diffuse large B-cell lymphoma.
Liu YZ; Xue K; Wang BS; Li CY; Lv FF; Jin J; Zhang QL; Xia ZG; Ji DM; Sun H; Wang JC; Liu XJ; Cao JN; Hong XN
Leuk Lymphoma; 2019 Apr; 60(4):934-939. PubMed ID: 30277105
[TBL] [Abstract][Full Text] [Related]
2. Anatomic distribution, clinical features, and survival data of 87 cases primary gastrointestinal lymphoma.
Ge Z; Liu Z; Hu X
World J Surg Oncol; 2016 Mar; 14():85. PubMed ID: 26988370
[TBL] [Abstract][Full Text] [Related]
3. Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Multicenter Study of 272 Cases from the China Lymphoma Patient Registry.
Yang H; Wu M; Shen Y; Lei T; Mi L; Leng X; Ping L; Xie Y; Song Y; Cen X; Zhu J
Int J Med Sci; 2019; 16(7):1023-1031. PubMed ID: 31341416
[No Abstract] [Full Text] [Related]
4. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication.
Tari A; Asaoku H; Kashiwado K; Yoshino T; Kitadai Y; Tanaka S; Fujihara M
Dig Endosc; 2009 Oct; 21(4):219-27. PubMed ID: 19961519
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
8. Prognostic significance of serum aspartic transaminase in diffuse large B-cell lymphoma.
Lu TX; Wu S; Cai DY; Hong TT; Zhang Y; Gao HQ; Hua HY; Wu XH
BMC Cancer; 2019 Jun; 19(1):553. PubMed ID: 31176361
[TBL] [Abstract][Full Text] [Related]
9. Primary gastrointestinal non-Hodgkin's lymphoma: clinicopathological and prognostic analysis.
Wang T; Gui W; Shen Q
Med Oncol; 2010 Sep; 27(3):661-6. PubMed ID: 19565363
[TBL] [Abstract][Full Text] [Related]
10. Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma.
Niu JY; Tian T; Zhu HY; Liang JH; Wu W; Cao L; Lu RN; Wang L; Li JY; Xu W
Ann Hematol; 2018 Oct; 97(10):1841-1849. PubMed ID: 29860562
[TBL] [Abstract][Full Text] [Related]
11. A clinically based prognostic index for diffuse large B-cell lymphoma with a cut-off at 70 years of age significantly improves prognostic stratification: population-based analysis from the Danish Lymphoma Registry.
Gang AO; Pedersen M; d'Amore F; Pedersen LM; Jensen BA; Jensen P; Møller MB; Mourits-Andersen HT; Pedersen RS; Klausen TW; de N Brown P
Leuk Lymphoma; 2015; 56(9):2556-62. PubMed ID: 25629994
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of primary gastric diffuse large B-cell lymphoma: Clinical diagnosis, staging, treatment and prognostic factors.
Bai Z; Zhou Y
Leuk Res; 2021 Dec; 111():106716. PubMed ID: 34627052
[TBL] [Abstract][Full Text] [Related]
13. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
[TBL] [Abstract][Full Text] [Related]
14. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte.
Morel P; Dupriez B; Herbrecht R; Bastion Y; Tilly H; Delannoy A; Haioun C; Nouvel C; Bouabdallah K; Baumelou E
Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172
[TBL] [Abstract][Full Text] [Related]
15. The impact of time from diagnosis to treatment in diffuse large B-cell lymphoma.
Phipps C; Lee YS; Ying H; Nagarajan C; Grigoropoulos N; Chen Y; Tang T; Goh AZ; Ghosh A; Ng HJ; Gopalakrishnan S; Loh Y; Lim ST; Hwang W; Tan D; Goh YT
Leuk Lymphoma; 2018 Oct; 59(10):2336-2341. PubMed ID: 29345210
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
[No Abstract] [Full Text] [Related]
17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
18. Primary gastric diffuse large B-cell lymphoma: The role of dose-dense chemotherapy.
Avilés A; Nambo MJ; Neri N
J Oncol Pharm Pract; 2019 Oct; 25(7):1682-1686. PubMed ID: 30370804
[TBL] [Abstract][Full Text] [Related]
19. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan KT; Melchardt T; Deutsch A; Schlick K; Stojakovic T; Bullock MD; Reitz D; Beham-Schmid C; Weiss L; Neureiter D; Wenzl K; Greil R; Neumeister P; Egle A; Pichler M
Eur J Haematol; 2015 Dec; 95(6):538-44. PubMed ID: 25677782
[TBL] [Abstract][Full Text] [Related]
20. Management of primary gastric lymphomas from a surgeon's viewpoint.
Ishizuka H; Kubota T; Hayashi N; Otani Y; Kumai K; Kitajima M
Oncol Rep; 1999; 6(1):103-6. PubMed ID: 9864410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
